{
    "info": {
        "nct_id": "NCT04527900",
        "official_title": "The \"Upproach\" Approach: A Phase 2 Study Of Upfront Intensity Modulated Proton Beam Therapy (Impt) And Concurrent Chemotherapy For Post-Operative Treatment In Loco-Regionally Advanced Endometrial Cancer",
        "inclusion_criteria": "1. Surgery must have included a hysterectomy. Bilateral salpingo-oophorectomy, pelvic lymph node sampling, para-aortic lymph node sampling, and omentectomy are optional\n2. Patients will be staged according to FIGO 2009 staging system. Eligibility is defined based on clinical-pathologic features.\n3. Patients with endometrioid endometrial cancer with the following:\n\n   * Stage IA grade 3 with extensive LVSI\n   * Stage IB grade 3\n   * Stage II\n   * Stage III (A, B, and C)\n   * Stage IVA who are recommended adjuvant whole pelvic RT (+/- lower para-aortic up to renal hilum) and systemic chemotherapy.\n4. Patients with clear cell, serous papillary carcinoma, or carcinosarcoma with stages IA-III who are recommended adjuvant whole pelvic RT (+/- lower para-aortic up to renal hilum) and systemic chemotherapy.\n5. Patients with a GOG Performance Status of 0, 1, or 2\n6. Patients with adequate organ function, reflected by the following parameters:\n\n   * WBC ≥ 3000/mcl\n   * Absolute neutrophil count (ANC) ≥ 1000/mcl\n   * Platelet count ≥ 100,000/mcl\n   * SGOT, SGPT, and alkaline phosphatase ≤ 2.5 X upper limit of normal (ULN)\n   * Bilirubin ≤ 1.5 X ULN\n   * Creatinine ≤ institutional ULN (if serum creatinine > ULN, estimated GFR ≥ 45 ml/min)\n7. Patients who have signed an approved informed consent and authorization permitting release of personal health information\n8. Patients must be 18 years of age or older\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Patients with leiomyosarcoma\n2. Patients with clinically significant pelvic or para-aortic nodal disease, on post-surgery CT scan, that was not dissected and would require higher boost dose\n3. Patients with recurrent endometrial cancer with gross nodal or vaginal disease requiring high dose radiotherapy, or history of prior chemotherapy\n4. Patients with a history of prior pelvic/abdominal RT or with history of prior cancer treatment that contraindicates this protocol therapy including history of prior chemotherapy for any other malignancy.\n5. Patients with a history of serious co-morbid illness or uncontrolled illnesses that would preclude protocol therapy\n6. Patients with an estimated survival of less than three months\n7. Patients with FIGO 2009 Stage IVB endometrial cancer\n8. Patients with a history of myocardial infarction, unstable angina, or uncontrolled arrhythmia within 3 months from enrollment",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Stage IA grade 3 with extensive LVSI",
            "criterions": [
                {
                    "exact_snippets": "Stage IA",
                    "criterion": "cancer stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "IA"
                        }
                    ]
                },
                {
                    "exact_snippets": "grade 3",
                    "criterion": "tumor grade",
                    "requirements": [
                        {
                            "requirement_type": "grade",
                            "expected_value": "3"
                        }
                    ]
                },
                {
                    "exact_snippets": "extensive LVSI",
                    "criterion": "lymphovascular space invasion (LVSI)",
                    "requirements": [
                        {
                            "requirement_type": "extent",
                            "expected_value": "extensive"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must be FEMALE",
            "criterions": [
                {
                    "exact_snippets": "Must be FEMALE",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Bilirubin ≤ 1.5 X ULN",
            "criterions": [
                {
                    "exact_snippets": "Bilirubin ≤ 1.5 X ULN",
                    "criterion": "bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.5,
                                "unit": "X ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* SGOT, SGPT, and alkaline phosphatase ≤ 2.5 X upper limit of normal (ULN)",
            "criterions": [
                {
                    "exact_snippets": "SGOT ... ≤ 2.5 X upper limit of normal (ULN)",
                    "criterion": "SGOT level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.5,
                                "unit": "x ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "SGPT ... ≤ 2.5 X upper limit of normal (ULN)",
                    "criterion": "SGPT level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.5,
                                "unit": "x ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "alkaline phosphatase ≤ 2.5 X upper limit of normal (ULN)",
                    "criterion": "alkaline phosphatase level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.5,
                                "unit": "x ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Patients with adequate organ function, reflected by the following parameters:",
            "criterions": [
                {
                    "exact_snippets": "adequate organ function",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* WBC ≥ 3000/mcl",
            "criterions": [
                {
                    "exact_snippets": "WBC ≥ 3000/mcl",
                    "criterion": "white blood cell count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3000,
                                "unit": "mcl"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Stage IVA who are recommended adjuvant whole pelvic RT (+/- lower para-aortic up to renal hilum) and systemic chemotherapy.",
            "criterions": [
                {
                    "exact_snippets": "Stage IVA",
                    "criterion": "cancer stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "IVA"
                        }
                    ]
                },
                {
                    "exact_snippets": "recommended adjuvant whole pelvic RT (+/- lower para-aortic up to renal hilum)",
                    "criterion": "adjuvant whole pelvic radiotherapy",
                    "requirements": [
                        {
                            "requirement_type": "recommendation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "recommended ... systemic chemotherapy",
                    "criterion": "systemic chemotherapy",
                    "requirements": [
                        {
                            "requirement_type": "recommendation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Stage IB grade 3",
            "criterions": [
                {
                    "exact_snippets": "Stage IB",
                    "criterion": "cancer stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "IB"
                        }
                    ]
                },
                {
                    "exact_snippets": "grade 3",
                    "criterion": "tumor grade",
                    "requirements": [
                        {
                            "requirement_type": "grade",
                            "expected_value": "3"
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Patients must be 18 years of age or older",
            "criterions": [
                {
                    "exact_snippets": "Patients must be 18 years of age or older",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Platelet count ≥ 100,000/mcl",
            "criterions": [
                {
                    "exact_snippets": "Platelet count ≥ 100,000/mcl",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100000,
                                "unit": "mcl"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Patients with a GOG Performance Status of 0, 1, or 2",
            "criterions": [
                {
                    "exact_snippets": "GOG Performance Status of 0, 1, or 2",
                    "criterion": "GOG Performance Status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": [
                                "0",
                                "1",
                                "2"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Stage II",
            "criterions": [
                {
                    "exact_snippets": "Stage II",
                    "criterion": "cancer stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "II"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Creatinine ≤ institutional ULN (if serum creatinine > ULN, estimated GFR ≥ 45 ml/min)",
            "criterions": [
                {
                    "exact_snippets": "Creatinine ≤ institutional ULN",
                    "criterion": "serum creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "institutional ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "if serum creatinine > ULN, estimated GFR ≥ 45 ml/min",
                    "criterion": "estimated glomerular filtration rate (GFR)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 45,
                                "unit": "ml/min"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Patients with endometrioid endometrial cancer with the following:",
            "criterions": [
                {
                    "exact_snippets": "endometrioid endometrial cancer",
                    "criterion": "endometrioid endometrial cancer",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Surgery must have included a hysterectomy. Bilateral salpingo-oophorectomy, pelvic lymph node sampling, para-aortic lymph node sampling, and omentectomy are optional",
            "criterions": [
                {
                    "exact_snippets": "Surgery must have included a hysterectomy.",
                    "criterion": "hysterectomy",
                    "requirements": [
                        {
                            "requirement_type": "history of procedure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Bilateral salpingo-oophorectomy, pelvic lymph node sampling, para-aortic lymph node sampling, and omentectomy are optional",
                    "criterion": "bilateral salpingo-oophorectomy",
                    "requirements": [
                        {
                            "requirement_type": "history of procedure",
                            "expected_value": "optional"
                        }
                    ]
                },
                {
                    "exact_snippets": "Bilateral salpingo-oophorectomy, pelvic lymph node sampling, para-aortic lymph node sampling, and omentectomy are optional",
                    "criterion": "pelvic lymph node sampling",
                    "requirements": [
                        {
                            "requirement_type": "history of procedure",
                            "expected_value": "optional"
                        }
                    ]
                },
                {
                    "exact_snippets": "Bilateral salpingo-oophorectomy, pelvic lymph node sampling, para-aortic lymph node sampling, and omentectomy are optional",
                    "criterion": "para-aortic lymph node sampling",
                    "requirements": [
                        {
                            "requirement_type": "history of procedure",
                            "expected_value": "optional"
                        }
                    ]
                },
                {
                    "exact_snippets": "Bilateral salpingo-oophorectomy, pelvic lymph node sampling, para-aortic lymph node sampling, and omentectomy are optional",
                    "criterion": "omentectomy",
                    "requirements": [
                        {
                            "requirement_type": "history of procedure",
                            "expected_value": "optional"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Stage III (A, B, and C)",
            "criterions": [
                {
                    "exact_snippets": "Stage III (A, B, and C)",
                    "criterion": "cancer stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "III A",
                                "III B",
                                "III C"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Patients with clear cell, serous papillary carcinoma, or carcinosarcoma with stages IA-III who are recommended adjuvant whole pelvic RT (+/- lower para-aortic up to renal hilum) and systemic chemotherapy.",
            "criterions": [
                {
                    "exact_snippets": "clear cell, serous papillary carcinoma, or carcinosarcoma",
                    "criterion": "histological subtype",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": [
                                "clear cell carcinoma",
                                "serous papillary carcinoma",
                                "carcinosarcoma"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "stages IA-III",
                    "criterion": "disease stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 1,
                                        "unit": "A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "recommended adjuvant whole pelvic RT (+/- lower para-aortic up to renal hilum) and systemic chemotherapy",
                    "criterion": "treatment recommendation",
                    "requirements": [
                        {
                            "requirement_type": "adjuvant whole pelvic RT",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "systemic chemotherapy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Patients will be staged according to FIGO 2009 staging system. Eligibility is defined based on clinical-pathologic features.",
            "criterions": [
                {
                    "exact_snippets": "staged according to FIGO 2009 staging system",
                    "criterion": "FIGO 2009 staging",
                    "requirements": [
                        {
                            "requirement_type": "staging_system",
                            "expected_value": "FIGO 2009"
                        }
                    ]
                },
                {
                    "exact_snippets": "Eligibility is defined based on clinical-pathologic features",
                    "criterion": "clinical-pathologic features",
                    "requirements": [
                        {
                            "requirement_type": "basis_for_eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Patients who have signed an approved informed consent and authorization permitting release of personal health information",
            "criterions": [
                {
                    "exact_snippets": "signed an approved informed consent",
                    "criterion": "informed consent",
                    "requirements": [
                        {
                            "requirement_type": "signed",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "approval status",
                            "expected_value": "approved"
                        }
                    ]
                },
                {
                    "exact_snippets": "authorization permitting release of personal health information",
                    "criterion": "authorization for release of personal health information",
                    "requirements": [
                        {
                            "requirement_type": "authorization",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Absolute neutrophil count (ANC) ≥ 1000/mcl",
            "criterions": [
                {
                    "exact_snippets": "Absolute neutrophil count (ANC) ≥ 1000/mcl",
                    "criterion": "absolute neutrophil count (ANC)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1000,
                                "unit": "mcl"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "3. Patients with recurrent endometrial cancer with gross nodal or vaginal disease requiring high dose radiotherapy, or history of prior chemotherapy",
            "criterions": [
                {
                    "exact_snippets": "recurrent endometrial cancer",
                    "criterion": "endometrial cancer",
                    "requirements": [
                        {
                            "requirement_type": "recurrence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "gross nodal or vaginal disease requiring high dose radiotherapy",
                    "criterion": "gross nodal or vaginal disease",
                    "requirements": [
                        {
                            "requirement_type": "location",
                            "expected_value": [
                                "nodal",
                                "vaginal"
                            ]
                        },
                        {
                            "requirement_type": "severity",
                            "expected_value": "gross"
                        },
                        {
                            "requirement_type": "treatment requirement",
                            "expected_value": "high dose radiotherapy"
                        }
                    ]
                },
                {
                    "exact_snippets": "history of prior chemotherapy",
                    "criterion": "chemotherapy",
                    "requirements": [
                        {
                            "requirement_type": "history of prior treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Patients with a history of myocardial infarction, unstable angina, or uncontrolled arrhythmia within 3 months from enrollment",
            "criterions": [
                {
                    "exact_snippets": "history of myocardial infarction ... within 3 months from enrollment",
                    "criterion": "myocardial infarction",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "months"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "history of ... unstable angina ... within 3 months from enrollment",
                    "criterion": "unstable angina",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "months"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "history of ... uncontrolled arrhythmia within 3 months from enrollment",
                    "criterion": "uncontrolled arrhythmia",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "months"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Patients with a history of serious co-morbid illness or uncontrolled illnesses that would preclude protocol therapy",
            "criterions": [
                {
                    "exact_snippets": "history of serious co-morbid illness",
                    "criterion": "serious co-morbid illness",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "uncontrolled illnesses that would preclude protocol therapy",
                    "criterion": "uncontrolled illnesses",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        },
                        {
                            "requirement_type": "impact on protocol therapy",
                            "expected_value": "would preclude protocol therapy"
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Patients with clinically significant pelvic or para-aortic nodal disease, on post-surgery CT scan, that was not dissected and would require higher boost dose",
            "criterions": [
                {
                    "exact_snippets": "clinically significant pelvic or para-aortic nodal disease",
                    "criterion": "pelvic or para-aortic nodal disease",
                    "requirements": [
                        {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "on post-surgery CT scan",
                    "criterion": "nodal disease detection method",
                    "requirements": [
                        {
                            "requirement_type": "detection method",
                            "expected_value": "post-surgery CT scan"
                        }
                    ]
                },
                {
                    "exact_snippets": "that was not dissected",
                    "criterion": "nodal disease dissection status",
                    "requirements": [
                        {
                            "requirement_type": "dissected",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "would require higher boost dose",
                    "criterion": "nodal disease radiation requirement",
                    "requirements": [
                        {
                            "requirement_type": "requires higher boost dose",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Patients with FIGO 2009 Stage IVB endometrial cancer",
            "criterions": [
                {
                    "exact_snippets": "Patients with FIGO 2009 Stage IVB endometrial cancer",
                    "criterion": "endometrial cancer",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "FIGO 2009 Stage IVB",
                    "criterion": "FIGO stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "IVB"
                        },
                        {
                            "requirement_type": "staging_system",
                            "expected_value": "FIGO 2009"
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Patients with a history of prior pelvic/abdominal RT or with history of prior cancer treatment that contraindicates this protocol therapy including history of prior chemotherapy for any other malignancy.",
            "criterions": [
                {
                    "exact_snippets": "history of prior pelvic/abdominal RT",
                    "criterion": "prior pelvic/abdominal radiotherapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history of prior cancer treatment that contraindicates this protocol therapy",
                    "criterion": "prior cancer treatment contraindicating protocol therapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "contraindication to protocol therapy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history of prior chemotherapy for any other malignancy",
                    "criterion": "prior chemotherapy for any other malignancy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Patients with an estimated survival of less than three months",
            "criterions": [
                {
                    "exact_snippets": "estimated survival of less than three months",
                    "criterion": "estimated survival",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": "<",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Patients with leiomyosarcoma",
            "criterions": [
                {
                    "exact_snippets": "Patients with leiomyosarcoma",
                    "criterion": "leiomyosarcoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}